Structure-activity relationships of histamine H2 receptor ligands

被引:31
|
作者
Dove, S
Elz, S
Seifert, R
Buschauer, A [1 ]
机构
[1] Univ Regensburg, Inst Pharm, D-93040 Regensburg, Germany
[2] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA
关键词
H-2 receptor agonists; H-2 receptor antagonists; impromidine analogues; arpromidine; molecular modelling; structure-activity relationships; QSAR; site-directed mutagenesis;
D O I
10.2174/1389557043403242
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Recent research on histamine H-2 receptor agonists was focused on quantitative structure-activity relationships and receptor models explaining the activity of imidazolylpropylguanidines. Their selectivity for guinea pig vs. human isoforms was investigated using H-2 receptor-G(salpha) fusion proteins and attributed to amino acid differences in transmembrane domains 1 and 7. New antagonists result from approaches to improve pharmacokinetic properties and to design hybrid drugs which additionally have gastroprotective or anti H. pylori activity.
引用
收藏
页码:941 / 954
页数:14
相关论文
共 50 条
  • [31] Structure-activity relationships of non-imidazole H3 receptor ligands.: Part 1
    Faghih, R
    Dwight, W
    Gentles, R
    Phelan, K
    Esbenshade, TA
    Ireland, L
    Miller, TR
    Kang, CH
    Fox, GB
    Gopalakrishnan, SM
    Hancock, AA
    Bennani, YL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (15) : 2031 - 2034
  • [32] Synthesis and Structure-Activity Relationships of Cyanoguanidine-Type and Structurally Related Histamine H4 Receptor Agonists
    Igel, Patrick
    Geyer, Roland
    Strasser, Andrea
    Dove, Stefan
    Seifert, Roland
    Buschauer, Armin
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (20) : 6297 - 6313
  • [33] Structure-activity relationships of arylbenzofuran H3 receptor antagonists
    Gfesser, GA
    Faghih, R
    Bennani, YL
    Curtis, MP
    Esbenshade, TA
    Hancock, AA
    Cowart, MD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (10) : 2559 - 2563
  • [34] Synthesis, structure-activity relationships, and biological profiles of a dihydrobenzoxathiin class of histamine H3 receptor inverse agonists
    Sasaki, Takahide
    Takahashi, Toshiyuki
    Nagase, Tsuyoshi
    Mizutani, Takashi
    Ito, Sayaka
    Mitobe, Yuko
    Miyamoto, Yasuhisa
    Kanesaka, Maki
    Yoshimoto, Ryo
    Tanaka, Takeshi
    Takenaga, Norihiro
    Tokita, Shigeru
    Sato, Nagaaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4232 - 4236
  • [35] SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF CONFORMATIONALLY CONSTRAINED CYANOGUANIDINES: POTENT AND SELECTIVE HISTAMINE H4 RECEPTOR AGONISTS
    Geyer, R.
    Igel, P.
    Bernhardt, G.
    Buschauer, A.
    INFLAMMATION RESEARCH, 2010, 59 : S353 - S354
  • [36] Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists
    Nagase, Tsuyoshi
    Mizutani, Takashi
    Ishikawa, Shiho
    Sekino, Etsuko
    Sasaki, Takahide
    Fujimura, Takashi
    Ito, Sayaka
    Mitobe, Yuko
    Miyamoto, Yasuhisa
    Yoshimoto, Ryo
    Tanaka, Takeshi
    Ishihara, Akane
    Takenaga, Norihiro
    Tokita, Shigeru
    Fukami, Takehiro
    Sato, Nagaaki
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (15) : 4780 - 4789
  • [37] Histamine H2 receptor trafficking: Role of arrestin, dynamin, and clathrin in histamine H2 receptor internalization
    Fernandez, Natalia
    Monczor, Federico
    Baldi, Alberto
    Davio, Carlos
    Shayo, Carina
    MOLECULAR PHARMACOLOGY, 2008, 74 (04) : 1109 - 1118
  • [38] Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists
    Tao, Ming
    Raddatz, Rita
    Aimone, Lisa D.
    Hudkins, Robert L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (20) : 6126 - 6130
  • [39] Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H3 receptor antagonists
    Linney, ID
    Buck, IM
    Harper, EA
    Kalindjian, SB
    Pether, MJ
    Shankley, NP
    Watt, GF
    Wright, PT
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (12) : 2362 - 2370
  • [40] Synthesis and structure-activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands: Part 2
    Caldwell, John P.
    Matasi, Julius J.
    Fernandez, Xiomara
    McLeod, Robbie L.
    Zhang, Hongtao
    Fawzi, Ahmad
    Tulshian, Deen B.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (04) : 1164 - 1167